BRKR is the ticker symbol for BRUKER CORP, a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks BRKR with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is BRKR a good stock to buy?

13F Pro's AI ranking engine scores BRKR at 49.8/100, ranked #1,655 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for BRKR is available at https://13fpro.ai/company/BRKR. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source BRKR data?

All BRUKER CORP fundamentals and ownership data come directly from SEC EDGAR. BRUKER CORP files with the SEC under CIK 1109354. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

BRUKER CORP BRKR

NasdaqMid CapHealthcare

13F Pro quality score

Rank #1,655 of 2,925

Why it scores 50 Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$838.50M

Quarter to Jun 30

Net income

$-52.00M

Quarter to Jun 30

Free cash flow

$-106.20M

Quarter to Jun 30

Operating margin

-7.8%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026

$9.66B total

FMR LLC

$1.42B+25.0%

Orbis Allan Gray Ltd

$1.08B0.0%

BlackRock, Inc.

$763.40M+1.8%

Pallas Capital Advisors LLC

$570.75M0.0%

VANGUARD PORTFOLIO MANAGEMENT LLC

$294.18M+0.7%

VANGUARD CAPITAL MANAGEMENT LLC

$292.43M+0.9%

Sculptor Capital LP

$286.37M+41.2%

FRANKLIN RESOURCES INC

$283.92M+9.9%

Aequim Alternative Investments LP

$258.76M+16.0%

STATE STREET CORP

$258.67M+2.9%

Sachem Head Capital Management LP

$175.42MNew

EDMOND DE ROTHSCHILD HOLDING S.A.

$169.90M-15.9%

DIMENSIONAL FUND ADVISORS LP

$157.07M+11.5%

AQR CAPITAL MANAGEMENT LLC

$149.49M+94.3%

LONDON CO OF VIRGINIA

$149.25M-4.0%

PRICE T ROWE ASSOCIATES INC /MD/

$147.94M-0.6%

GEODE CAPITAL MANAGEMENT, LLC

$136.96M+2.3%

FIRST TRUST ADVISORS LP

$124.33M+38.4%

MORGAN STANLEY

$123.47M-0.2%

D. E. Shaw & Co., Inc.

$99.66M+35.8%

Artisan Partners Limited Partnership

$89.77M+4.5%

BROWN ADVISORY INC

$86.91M-18.9%

SNYDER CAPITAL MANAGEMENT L P

$85.96M-2.7%

Alyeska Investment Group, L.P.

$84.86M+86.2%

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

$84.20M-2.4%

See all 433 institutional holders →

What's Driving BRKR's Business? Latest 10-Q Breakdown

24/24 datapoints verified

AI-extracted from the 10-Q filed 2026-08-05 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Bruker reported Q2 revenue of $838.5M (+5.2% YoY) but swung to a $65.3M operating loss due to $134.9M goodwill impairment charges in BioSpin and NANO segments.

Biggest Revenue Drivers

BSI CALID$310.3M+8.6% YoY

Driven by impact of recent acquisitions and increased revenue from academic/government research and biotech/pharma markets.

BSI NANO$261.3M+3.6% YoY

Remained consistent with prior year period.

Biggest Revenue Drivers

Total revenue: $838.5M+5.2% YoY

BSI CALID$310.3M+8.6% YoY

Driven by impact of recent acquisitions and increased revenue from academic/government research and biotech/pharma markets.

BSI NANO$261.3M+3.6% YoY

Remained consistent with prior year period.

BSI BioSpin$195.7M+0.2% YoY

Revenue remained consistent during the quarter.

BEST$74.2M+11.9% YoY

Growth driven by superconductor business and fusion energy/high-energy physics technologies.

Largest Expense Items

Goodwill impairment charge$134.9MN/A

Impairment of BSI BioSpin Chemspeed Technologies ($98.4M) and BSI NANO Bruker Spatial Biology ($36.5M) reporting units due to reduced revenue and cash flow forecasts.

Cost of revenue$422.5M-3.9% YoY

Decrease driven by cost savings initiatives, positive net U.S. tariffs impact, and higher revenue volume.

Selling, general and administrative$238.9M+3.2% YoY

Impact of cost savings initiatives offset by acquisitions, foreign exchange headwinds, and cost inflation.

Research and development$94.3M-5.9% YoY

Decrease driven by cost saving initiatives.

Margins: Gross margin expanded to 49.6% from 44.9% YoY due to cost savings, tariff refunds, and revenue volume, but operating margin deteriorated sharply to -7.8% from +1.5% due to the $134.9M goodwill impairment charges and foreign exchange headwinds.

Watch Items from the Filing

$134.9M goodwill impairment charges recorded in Q2 2026 across two reporting units (BSI BioSpin Chemspeed $98.4M, BSI NANO Bruker Spatial Biology $36.5M) due to reduced revenue/cash flow forecasts.
Post-June 30 segment reorganization triggered interim goodwill impairment analysis on several reporting units; additional impairment charges expected in Q3 2026.
BSI BioSpin segment operating loss of $64.6M in Q2 2026 versus $18.1M operating income in Q2 2025, driven primarily by goodwill impairment of CST reporting unit.
Asia Pacific revenue declined 10.2% YoY in Q2 2026 and 10.3% YoY for six months ended June 30, 2026, reflecting weakness in key geographic markets.
Company completed settlement of patent litigation with 10x Genomics and AbCellera in first half of 2026; all settlement payments made and no remaining liabilities outstanding.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →

Key Metrics

Revenue

Q2 2026

EDGAR

Net Income

Q2 2026

EDGAR

EPS (Diluted)

Q2 2026

EDGAR

Operating Margin

Q2 2026

EDGAR

ROIC

Q2 2026

EDGAR

Free Cash Flow

Q2 2026

EDGAR

Debt/Equity

Q2 2026

EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/BRKR

Earnings Per Share

13fpro.ai/company/BRKR

Loading ratio trend…

BRUKER CORP reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Op. marginOperating margin
FY 2025	10-K	$3.4B	$-8.6M	2.0%
FY 2024	10-K	$3.4B	$113.1M	7.5%
FY 2023	10-K	$3.0B	$427.2M	14.7%
FY 2022	10-K	$2.5B	$296.6M	17.1%
FY 2021	10-K	$2.4B	$277.1M	17.1%
FY 2020	10-K	$2.0B	$157.8M	12.5%

About BRUKER CORP (BRKR): stock profile, AI score and financials

BRUKER CORP (BRKR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BRKR at 49.8/100 on a composite quality score built from its SEC filings, placing it at rank #1,655 of 2,925 stocks — the bottom half of the AI-ranked universe. BRKR scores in the top quartile across earnings quality (88.6). Areas of concern include profitability (24.9) and balance sheet strength (30.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), BRUKER CORP reports quarterly revenue of $838.5M, net income of $-52.0M, an operating margin of -7.8%. Top institutional holders of BRKR by reported 13-F value include FMR, Orbis Allan Gray Ltd, BlackRock, based on the most recent SEC filings. BRKR trades on the Nasdaq exchange and files with the SEC under CIK 1109354. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BRKR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BRUKER CORP directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1109354 →

BRUKER CORP BRKR

Top Institutional Holders

What's Driving BRKR's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Biggest Revenue Drivers

Largest Expense Items

Watch Items from the Filing

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

BRKR key financials by period

BRKR insiders

About BRUKER CORP (BRKR): stock profile, AI score and financials

BRUKER CORP BRKR

Top Institutional Holders

What's Driving BRKR's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

BRKR key financials by period

Companies similar to BRKR

BRKR insiders

About BRUKER CORP (BRKR): stock profile, AI score and financials